Production (Stage)
Universal Ibogaine Inc.
IBOGF
$0.018
-$0.0003-1.64%
OTC PK
04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
---|---|---|---|---|---|
Net Income | 7.42% | -88.71% | -23.51% | 15.38% | 75.03% |
Total Depreciation and Amortization | 0.73% | 4.30% | 7.48% | 14.55% | 14.48% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 32.84% | 431.92% | 158.42% | 115.90% | -84.22% |
Change in Net Operating Assets | -361.14% | -176.59% | -172.01% | -145.34% | 84.23% |
Cash from Operations | 16.27% | -143.79% | -7.59% | 24.49% | 74.40% |
Capital Expenditure | 73.08% | 60.14% | 83.82% | 78.47% | 78.78% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | -- | -- | -- | -- |
Cash from Investing | 73.08% | 60.14% | 83.82% | 78.47% | -125.98% |
Total Debt Issued | -- | -- | -- | -- | -100.00% |
Total Debt Repaid | -65.66% | -111.71% | -148.02% | -213.35% | 20.16% |
Issuance of Common Stock | -84.40% | 190.70% | 1,430.00% | 202.13% | 161.35% |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | 194.78% | -240.63% | -- | -- | -- |
Cash from Financing | -67.56% | 39.51% | 49.57% | -7.59% | -1.56% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -390.08% | -155.40% | 88.22% | 114.32% | 107.04% |